T-CELL DIFFERENTIATION: MOLECULAR MECHANISMS
T-CELL DIFFERENTIATION: MOLECULAR MECHANISMS
批准号:
3166999
负责人:
EDWARD A BOYSE
金额:
$19.14万
依托单位国家:
美国
项目类别:
财政年份:
1978
资助国家:
美国
项目状态:
已结题
起止时间:
1978-09-30 至 1986-07-31
关键词:
B lymphocyte T lymphocyte autoimmune disorder autoradiography cell differentiation density gradient ultracentrifugation flow cytometry gel electrophoresis gene expression immunization immunodiffusion immunofluorescence technique immunogenetics immunoregulation membrane activity molecular biology monoclonal antibody murine leukemia virus nucleic acid inhibitor nucleotidyltransferase radioimmunoassay thymopoietin transforming virus
中文摘要
T细胞分化调控的各个方面和模型如下
地址。
有证据表明,某些T细胞淋巴瘤克隆可诱导
体外表达Lyt-1。Lyt-1基因表达的阻断及其伴随
Ly-5单抗产生IL-2,以及其他数据向我们暗示
Pre-Lyl细胞上的Ly-5参与了IL-1依赖的阶梯引导
对IL-2的产生和Lyl表型的影响。我们的目标是描述这一点
在转录和翻译方面的过渡。
我们发现重组γ-干扰素可以诱导LYB-2和
获得B系细胞的Sig表面表型。一个特殊的点
有趣的是,这需要的伽马干扰素远远少于
常规病毒保护(CPE)试验。因此,伽马干扰素可以
值得考虑作为淋巴细胞分化剂,即使在
普通CPE化验不能显示其存在的情况。
B细胞亚群和Ly1细胞表达Lyt-1的意义
而Ly123组T细胞则鲜为人知。我们的目标是阐明诱导的
我们在有丝分裂原刺激的克隆性B细胞中观察到Lyt-1的增强
转录和翻译术语与T细胞的比较。
所描述的克隆性Abelson淋巴瘤株产生一个主要的B
在培养中表达Ly-5 220K亚型但占主导地位的群体
体内表达200K亚型的T群体。如果这个概念是正确的
因此,原始的转化细胞是
淋巴细胞,我们有一个有价值的模型,可以选择不同的选择
(T与B),用于研究谱系相关异构体的调节
表情。我们的目标首先是确定替代路线是否
所采用的这些Abelson线路实际上符合正常的T和B
Ly-5转录和翻译方面的谱系。
关于220K(类B)Ly-5产物的异常表达
我们在LPR/LPR和LPR不断扩大的Ly1 T细胞群中观察到
GLD/GLD小鼠淋巴增殖综合征,我们的目标是解决
这个220K与220K异构体是否无法区分的问题
正常B细胞或Ly1细胞特有的增殖产物,无论是
这种增殖是正常的还是不正常的。(磅)
英文摘要
Various aspects and models of the regulation of T-cell differentiation are
addressed.
Evidence is given that certain T-cell lymphoma clones are inducible to
express Lyt-1 in vitro. The blocking of Lyt-1 expression and accompanying
IL-2 production by Ly-5 monoclonal antibody, and other data, suggest to us
that Ly-5 on pre-Lyl cells is involved in the IL-1 dependent step leading
to IL-2 production and the Lyl phenotype. We aim to characterize this
transition in terms of transcription and translation.
We find that recombinant gamma-interferon can induce the Lyb-2 and
suceeding sIg surface phenotypes of B lineage cells. A point of special
interest is that this requires far less gamma-interferon than is needed in
conventional virus-protection (CPE) assay. Gamma-interferon may thus
deserve consideration as an agent of lymphocyte differentiation even in
circumstances where ordinary CPE assay does not reveal its presence.
The meaning of Lyt-1 expression by a sub-set of B cells as well as the Ly1
and Ly123 sets of T cells is obscure. We aim to elucidate the induced
augmentation of Lyt-1 we observe in mitogen-stimulated clonal B cells, in
terms of transcription and translation in comparison with T cells.
The clonal Abelson lymphoma lines described generate a predominant B
population expressing the 220K isoform of Ly-5 in culture but a predominant
T population expressing the 200K isoform in vivo. If the notion is correct
that the originating transformed cell was therefore the progenitor cell for
lymphocytes, we have a valuable model of alternative differentional options
(T versus B) with which to study the regulation of lineage-related isoform
expression. We aim first to determine whether the alternative routes
adopted by these Abelson lines in fact conform to the normal T and B
lineages in terms of Ly-5 transcription and translation.
With regard to the aberrant expression of a 220K (B-like) Ly-5 product
which we observe in the expanding Ly1 T cell population of lpr/lpr and
gld/gld mice with lympho-proliferative syndrome, we aim to settle the
question of whether this 220K is indistinguishable from the 220K isoforms
of normal B cells or a product peculiar to proliferating Ly1 cells, whether
that proliferation is normal or abnormal. (LB)
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NORMAL AND ABNORMAL CELL SURFACE GENETICS
-
批准号:3479141
-
项目类别:
-
资助金额:$53.38万
-
财政年份:1985
-
负责人:EDWARD A BOYSE
-
依托单位:
NORMAL AND ABNORMAL CELL SURFACE GENETICS
-
批准号:3479140
-
项目类别:
-
资助金额:$87.85万
-
财政年份:1985
-
负责人:EDWARD A BOYSE
-
依托单位:
NORMAL AND ABNORMAL CELL SURFACE GENETICS
-
批准号:3479138
-
项目类别:
-
资助金额:$37.47万
-
财政年份:1985
-
负责人:EDWARD A BOYSE
-
依托单位:
NORMAL AND ABNORMAL CELL SURFACE GENETICS
-
批准号:3479139
-
项目类别:
-
资助金额:$90.05万
-
财政年份:1985
-
负责人:EDWARD A BOYSE
-
依托单位:
NORMAL AND ABNORMAL CELL SURFACE GENETICS
-
批准号:3479136
-
项目类别:
-
资助金额:$87.38万
-
财政年份:1985
-
负责人:EDWARD A BOYSE
-
依托单位:
NORMAL AND ABNORMAL CELL SURFACE GENETICS
-
批准号:3479135
-
项目类别:
-
资助金额:$11.5万
-
财政年份:1985
-
负责人:EDWARD A BOYSE
-
依托单位:
NORMAL AND ABNORMAL CELL SURFACE GENETICS
-
批准号:3479142
-
项目类别:
-
资助金额:$54.01万
-
财政年份:1985
-
负责人:EDWARD A BOYSE
-
依托单位:
NORMAL AND ABNORMAL CELL SURFACE GENETICS
-
批准号:3479137
-
项目类别:
-
资助金额:$95.02万
-
财政年份:1985
-
负责人:EDWARD A BOYSE
-
依托单位:
NORMAL AND ABNORMAL CELL SURFACE GENETICS
-
批准号:3479133
-
项目类别:
-
资助金额:$47.91万
-
财政年份:1985
-
负责人:EDWARD A BOYSE
-
依托单位:
METHODS TO PREPARE ALLOANTISERA
-
批准号:3592964
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1981
-
负责人:EDWARD A BOYSE
-
依托单位:
METHODS TO PREPARE ALLOANTISERA
-
批准号:3592962
-
项目类别:
-
资助金额:$19.14万
-
财政年份:1981
-
负责人:EDWARD A BOYSE
-
依托单位:
METHODS TO PREPARE ALLOANTISERA
-
批准号:3592965
-
项目类别:
-
资助金额:$20.48万
-
财政年份:1981
-
负责人:EDWARD A BOYSE
-
依托单位:
IMMUNOGENETICS OF LY SYSTEMS
-
批准号:3165731
-
项目类别:
-
资助金额:$32.76万
-
财政年份:1977
-
负责人:EDWARD A BOYSE
-
依托单位:
T CELL DEVELOPMENT: IMMUNOGENETICS, DEFECTS, THERAPY
-
批准号:3165786
-
项目类别:
-
资助金额:$19.86万
-
财政年份:1977
-
负责人:EDWARD A BOYSE
-
依托单位:
海外基金